Gwendolyn M. Swarbrick

Feb 23, 2024 | nature.com | Corinna A. Kulicke |Gwendolyn M. Swarbrick |Aneta H. Worley |Fikadu Tafesse |Andrew Olive |William Hildebrand | +5 more

AbstractMR1-restricted T cells have been implicated in microbial infections, sterile inflammation, wound healing and cancer. Similar to other antigen presentation molecules, evidence supports multiple, complementary MR1 antigen presentation pathways. To investigate ligand exchange pathways for MR1, we used MR1 monomers and tetramers loaded with 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil (5-OP-RU) to deliver the antigen.

Nov 14, 2023 | mdpi.com | Erin Morrow |Sarah Kiguli |Gwendolyn M. Swarbrick |Qijia Liu

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.